SUDEEPPHRM.NS
SUDEEPPHRM · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for SUDEEPPHRM.NS quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Copy of Newspaper Publication
11 Jul 2026
Record Date
10 Jul 2026
Updates
10 Jul 2026
Shareholders meeting
10 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 Jul 2026
Outcome of Board Meeting
26 Jun 2026
Appointment
26 Jun 2026
Trading Window
25 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
28 May 2026
Analysts/Institutional Investor Meet/Con. Call Updates
23 May 2026
Analysts/Institutional Investor Meet/Con. Call Updates
22 May 2026
Copy of Newspaper Publication
22 May 2026
Investor Presentation
22 May 2026
Dividend
21 May 2026
Outcome of Board Meeting
21 May 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Dividend - Rs 1.50 Per Share
Dividend - Rs 1.50 Per Share
Ex-date: 23 Jul 2026
Board Meetings
21 May 2026
SUDEEP PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 21-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend/Other business.
21 May 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
06 Feb 2026
SUDEEP PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 06-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.
06 Feb 2026
To consider and approve the financial results for the period ended December 31, 2025 and other business matters
19 Dec 2025
SUDEEP PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 19-Dec-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 .
19 Dec 2025
To consider and approve the financial results for the period ended September 30, 2025 and other business matters